Black Titan (NASDAQ:BTTC – Get Free Report) and Accenture (NYSE:ACN – Get Free Report) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.
Profitability
This table compares Black Titan and Accenture’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Black Titan | N/A | N/A | N/A |
| Accenture | 10.66% | 26.47% | 12.89% |
Analyst Recommendations
This is a summary of recent ratings for Black Titan and Accenture, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Black Titan | 1 | 0 | 0 | 0 | 1.00 |
| Accenture | 1 | 16 | 10 | 0 | 2.33 |
Institutional & Insider Ownership
75.1% of Accenture shares are held by institutional investors. 53.7% of Black Titan shares are held by company insiders. Comparatively, 0.0% of Accenture shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Black Titan and Accenture”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Black Titan | $180,000.00 | 21.84 | -$4.71 million | ($2.95) | -0.12 |
| Accenture | $69.67 billion | 1.73 | $7.68 billion | $12.52 | 14.45 |
Accenture has higher revenue and earnings than Black Titan. Black Titan is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Black Titan has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Accenture has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.
Summary
Accenture beats Black Titan on 11 of the 14 factors compared between the two stocks.
About Black Titan
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
About Accenture
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services. It also provides change management, HR transformation and delivery, organization strategy and design, talent strategy and development, and leadership and culture services; digital commerce; infrastructure services, including cloud infrastructure managed, cloud and data center, network, digital workplace, database platforms, service management, and cloud and infrastructure security services; data-enabled operating models; technology consulting and AI services; and technology consulting services. In addition, the company offers engineering and R&D digitization, smart connected products, product as-a-service enablement, capital projects, intelligent asset management, digital industrial workforce, and autonomous robotic systems; business process outsourcing; and services related to technology innovation. Further, it provides cloud, ecosystem, marketing, security, supply chain management, zero-based transformation, customer experience, finance consulting, mergers and acquisitions, and sustainability services. The company has a collaboration with Salesforce, Inc. to develop Salesforce Life Sciences Cloud. The company was founded in 1951 and is based in Dublin, Ireland.
Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.
